Evotec SE (EVO) EBT (2020 - 2025)

Evotec SE has disclosed EBT across 6 years of filings, most recently posting -$100.9 million for Q4 2025.

• EBT for Q4 2025 came in at -$100.9 million, up 51.3% year-over-year; the trailing twelve-month figure through Dec 2025 was -$308.1 million (down 4.87% YoY), and the FY2025 annual result was -$101.0 million, up 51.27% from the prior year.
• EBT came in at -$100.9 million for Q4 2025 at Evotec SE, down from -$50222.6 in the prior quarter.
• In the past five years, EBT ranged from a high of $270.8 million in Q4 2021 to a low of -$207.1 million in Q4 2024.
• The 5-year median for EBT is -$25967.9 (2022), against an average of -$18.7 million.
• Across the five-year window, EBT surged 1784.32% in 2021 and slumped 258.07% in 2024, its largest moves.
• Evotec SE's EBT stood at $270.8 million in 2021, then sank by 158.05% to -$157.2 million in 2022, then soared by 44.88% to -$86.7 million in 2023, then slumped by 138.99% to -$207.1 million in 2024, then surged by 51.3% to -$100.9 million in 2025.
• The last three EBT figures came in at -$100.9 million (Q4 2025), -$50222.6 (Q3 2025), and -$207.1 million (Q4 2024), per Business Quant data.